Literature DB >> 24390221

Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schönlein purpura nephritis in adults.

Chan Ho Kim1, Beom Jin Lim2, Yoon Sung Bae2, Young Eun Kwon1, Yung Ly Kim1, Ki Heon Nam1, Kyoung Sook Park1, Seong Yeong An1, Hyang Mo Koo1, Fa Mee Doh1, Mi Jung Lee1, Hyung Jung Oh1, Tae-Hyun Yoo1, Shin-Wook Kang3, Kyu Hun Choi1, Hyun Joo Jeong2, Seung Hyeok Han1.   

Abstract

Recently, there has been emerging concern that crescents, the main histologic feature of Henoch-Schönlein purpura nephritis, merely reflect active inflammation, and may not be useful in predicting long-term outcomes. We therefore conducted a single-center retrospective study to evaluate whether the new Oxford classification of immunoglobulin A nephropathy can be used to predict long-term outcome in patients with Henoch-Schönlein purpura nephritis. We included 61 biopsy-proven patients with Henoch-Schönlein purpura nephritis between January 1991 and August 2010. In addition to the International Study of Kidney Disease in Children classification, pathologic findings were also evaluated by the Oxford classification. Primary outcomes were defined as either the onset of estimated glomerular filtration rate <60 ml/min per 1.73 m(2) with ≥30% decrease in estimated glomerular filtration rate from baseline or end-stage renal disease. During a median follow-up of 49.3 months, 13 (21%) patients reached the primary end point. A Kaplan-Meier plot showed that renal event-free survival was significantly longer in patients with <50% crescents than in those with crescents in ≥50% of glomeruli (P=0.003). Among the components of the Oxford classification, patients with endocapillary hypercellularity (E1; P=0.016) and tubular atrophy/interstitial fibrosis (T1/T2; P=0.018) had lower renal survival rates than those with E0 and T0. In a multivariate Cox model adjusted for clinical and pathologic factors, E1 (hazard ratio=8.91; 95% confidence interval=1.47-53.88; P=0.017) and T1/T2 (hazard ratio=8.74; 95% confidence interval=1.40-54.38; P=0.020) were independently associated with reaching a primary outcome, whereas the extent of crescentic lesions was not. Our findings suggest that the Oxford classification can be used in predicting long-term outcomes of Henoch-Schönlein purpura nephritis.

Entities:  

Mesh:

Year:  2014        PMID: 24390221     DOI: 10.1038/modpathol.2013.222

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  26 in total

1.  The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis.

Authors:  Mikael Koskela; Elisa Ylinen; Elli-Maija Ukonmaanaho; Helena Autio-Harmainen; Päivi Heikkilä; Jouko Lohi; Outi Jauhola; Jaana Ronkainen; Timo Jahnukainen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2017-02-14       Impact factor: 3.714

2.  Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.

Authors:  Ke Xu; Lili Zhang; Jie Ding; Suxia Wang; Baige Su; Huijie Xiao; Fang Wang; Xuhui Zhong; Yanming Li
Journal:  J Nephrol       Date:  2017-11-28       Impact factor: 3.902

3.  Crescent lesions are not a predictive factor in adult-onset Henoch-Schönlein purpura nephritis.

Authors:  Zheng-Xia Zhong; Jia-Xing Tan; Yi Tang; Li Tan; Gai-Qin Pei; Wei Qin
Journal:  Clin Exp Med       Date:  2019-07-10       Impact factor: 3.984

4.  Histological prognostic factors in children with Henoch-Schönlein purpura nephritis.

Authors:  Jean-Daniel Delbet; Guillaume Geslain; Martin Auger; Julien Hogan; Rémi Salomon; Michel Peuchmaur; Georges Deschênes; David Buob; Cyrielle Parmentier; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2019-11-06       Impact factor: 3.714

5.  Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis?

Authors:  Adam Jimenez; Ashton Chen; Jen-Jar Lin; Andrew M South
Journal:  Pediatr Nephrol       Date:  2019-08-11       Impact factor: 3.714

6.  Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.

Authors:  Jean Daniel Delbet; Julien Hogan; Bilal Aoun; Iulia Stoica; Rémi Salomon; Stéphane Decramer; Isabelle Brocheriou; Georges Deschênes; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2017-02-15       Impact factor: 3.714

Review 7.  IgA vasculitis nephritis in children and adults: one or different entities?

Authors:  Licia Peruzzi; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2020-11-20       Impact factor: 3.714

8.  Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.

Authors:  Meral Torun Bayram; Cihan Heybeli; Gizem Yıldız; Alper Soylu; Ali Celik; Sülen Sarioglu; Salih Kavukçu
Journal:  Int Urol Nephrol       Date:  2021-11-30       Impact factor: 2.266

9.  Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.

Authors:  Izabel M Buscatti; Beatriz B Casella; Nadia E Aikawa; Andrea Watanabe; Sylvia C L Farhat; Lucia M A Campos; Clovis Artur Silva
Journal:  Clin Rheumatol       Date:  2018-01-13       Impact factor: 2.980

Review 10.  IgA Vasculitis and IgA Nephropathy: Same Disease?

Authors:  Evangeline Pillebout
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.